Andrew Buglass

Develops and offers animal medicines

Develops, registers and markets pharmaceutical products for global animal health markets

Manufactures and distributes pharmaceutical products intended for animals

Functions as a College/University

Engages in the distribution of electricity

Buglass Energy Advisory Ltd. is a consultancy specializing in strategic, commercial, and financing advice within the energy sector, supporting clients through the energy transition. The private company is based in London, UK. The British company provides tailored solutions to corporates seeking growth and innovation strategies, government bodies aiming to enhance policies with investor insights, and energy consultancies requiring commercial and investment expertise. The company was founded by Andrew Buglass.

Part of ECO Animal Health Group Plc, ECO Animal Health Japan, Inc. is a Japanese company that specializes in veterinary pharmaceuticals and solutions for livestock and poultry health, focusing primarily on pigs, chickens, and cattle. The company is based in Tokyo, Japan. The company offers products including macrolide antibiotics such as ibrosin® water-soluble powder and ibrosin plus feed additives containing tylvalosin tartrate, which are effective against mycoplasma and gram-positive bacteria. Its antiparasitic portfolio features ivermectin-based formulations under the ecomectin® brand, including injectable, topical, and feed premix products designed to control internal and external parasites in pigs and cattle. ECO Animal Health Japan provides veterinary professionals with technical information, research materials, educational columns, dosage guidelines, and practical tools to support disease management and sustainable livestock production.